ArticleClinical breast cancerPublished
Detrimental Impact of Chemotherapy Dose Reduction or Discontinuation in Early Stage Triple-Negative Breast Cancer Treated With Pembrolizumab and Neoadjuvant Chemotherapy: A Multicenter Experience
Regional connection
Verified An author affiliation on the Europe PMC record names Fox Chase Cancer Center, with Temple Health linked by the institution reference. Affiliation source
- Institutions
- Fox Chase Cancer Center, Temple Health
- County
- Philadelphia County
Publication record
- Type
- Article
- Venue
- Clinical breast cancer
- Published
- Topic
- Clinical care
- Subject terms
- Humans; Antineoplastic Combined Chemotherapy Protocols; Neoplasm Staging; Chemotherapy, Adjuvant; Neoadjuvant Therapy; Retrospective Studies; Adult; Middle Aged; Female; Antibodies, Monoclonal, Humanized; Triple Negative Breast Neoplasms; Antineoplastic Agents, Immunological
- PubMed ID
- 39198116
- PubMed Central ID
- PMC12838138
- Open access
- Yes, accepted manuscript
- Added to directory
- Source checked